← Eichor
Condition: Treatment Refractory Schizophrenia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Treatment Refractory Schizophrenia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of th
Phase 2/Phase 3 · 1 location(s) · SyneuRx International (Taiwan) Corp · NCT03094429
Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.
NA · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06505668
Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant
Phase 3 · 10 location(s) · Newron Pharmaceuticals SPA · NCT07184619
Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
NA · 1 location(s) · Boston VA Research Institute, Inc. · NCT05299749
Magnetic Seizure Therapy for Schizophrenia - Trial
NA · 2 location(s) · Centre for Addiction and Mental Health · NCT06672588
Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate
Phase 2 · 1 location(s) · National Cheng-Kung University Hospital · NCT06340789
Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
NA · 14 location(s) · Central Institute of Mental Health, Mannheim · NCT06456983
Acetazolamide for Treatment Resistant Schizophrenia
Phase 1/Phase 2 · 2 location(s) · Vishwajit Nimgaonkar, MD PhD · NCT04887792
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
NA · 1 location(s) · University Hospital, Lille · NCT04798131
Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia
NA · 1 location(s) · Jimmi Nielsen · NCT06749444
Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders
NA · 1 location(s) · Shanghai Mental Health Center · NCT06112067
Deep Brain Stimulation for Psychosis
NA · 1 location(s) · Bradley Lega · NCT06257056
Reduction of Auditory-Verbal Hallucinations in Schizophrenia Through Cortical Neuromodulation
NA · 1 location(s) · Centre Hospitalier St Anne · NCT06361160
Dundrum Forensic Redevelopment Evaluation Study: D-FOREST Study.
Phase N/A · 1 location(s) · Health Service Executive, Ireland · NCT05074732
SEEG-Guided DBS for Schizophrenia
NA · 1 location(s) · Ruijin Hospital · NCT07671261
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.